The last years have seen a remarkable growth in methods that allow large scale insight into cell phenotypes, gene and protein changes. These methods become increasingly common in the field of pulmonary vascular research and carry great promise not only for a better understanding of the pathophysiology, but also for a phenotyping of subtypes of patients as a prerequisite for precision medicine. The session will demonstrate to the attendee how these methodologies can be used to receive a holistic view on pulmonary vascular diseases and thus lead to a better stratification of patients and a more targeted treatment.
• Define the novel unbiased and large scale Omics and phenotyping methods available to pulmonary vascular researchers
• Increase understanding of pulmonary vascular cell phenotype and function through Omics, visualization and deep phenotyping
• Acquire knowledge on how Omics and deep phenotyping can influence the clinical-translational understanding of patients with pulmonary vascular disease and can support precision-targeted therapy
Stephen Chan, MD, PhD
Charles Dela Cruz, MD, PhD, ATSF
Anna Hemnes, MD, ATSF
Marlene Rabinovitch, MD
Beyond RNA - Multi-Dimensional -Omics in the Pulmonary Circulation
Advancing the Understanding of the Immune Response and Inflammation in the Lung Through Omics - Session withheld at the speaker's request
PVDOMICs - Molecular-Based Phenotyping of Pulmonary Vascular Diseases
From Omics to Targeted Treatment Options in Pulmonary Vascular Disease - Session withheld at the speaker's request